CLDX – Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.CLDX
$19.62Name : Celldex Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,302,654,208.00
EPSttm : -2.7
Celldex Therapeutics, Inc.
$19.62
2.78%$0.56Float Short %
13.92
Margin Of Safety %
Put/Call OI Ratio
0.64
EPS Next Q Diff
-0.08
EPS Last/This Y
-0.98
EPS This/Next Y
-0.61
Price
19.62
Target Price
57.25
Analyst Recom
1.15
Performance Q
-10.45
Relative Volume
0.9
Beta
1.35
Ticker: CLDX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | CLDX | 17.79 | 0.78 | 0.14 | 5375 |
| 2025-04-15 | CLDX | 18.35 | 0.75 | 7.67 | 5307 |
| 2025-04-16 | CLDX | 17.81 | 0.76 | 54.90 | 5309 |
| 2025-04-17 | CLDX | 18.31 | 0.92 | 0.33 | 5828 |
| 2025-04-18 | CLDX | 18.3 | 0.92 | 0.33 | 5828 |
| 2025-04-21 | CLDX | 18.97 | 0.93 | 0.00 | 5747 |
| 2025-04-22 | CLDX | 19.38 | 0.92 | 0.00 | 5794 |
| 2025-04-23 | CLDX | 19.44 | 0.91 | 0.32 | 5809 |
| 2025-04-24 | CLDX | 19.58 | 0.90 | 0.00 | 5819 |
| 2025-04-25 | CLDX | 19.57 | 0.90590163934426 | 0 | 5813 |
| 2025-04-28 | CLDX | 21.36 | 0.86614420062696 | 0 | 5953 |
| 2025-04-29 | CLDX | 20.96 | 0.66 | 55.94 | 6948 |
| 2025-04-30 | CLDX | 20.83 | 0.78 | 1.77 | 7463 |
| 2025-05-01 | CLDX | 20.68 | 0.78 | 0.00 | 7493 |
| 2025-05-02 | CLDX | 20.66 | 0.71 | 0.50 | 7937 |
| 2025-05-05 | CLDX | 20.27 | 0.71 | 1.00 | 7937 |
| 2025-05-06 | CLDX | 18.4 | 0.71 | 0.25 | 7944 |
| 2025-05-07 | CLDX | 18.9 | 0.71 | 0.00 | 7954 |
| 2025-05-08 | CLDX | 19.52 | 0.68 | 0.67 | 8172 |
| 2025-05-09 | CLDX | 18.34 | 0.67 | 0.31 | 8231 |
| 2025-05-12 | CLDX | 20.18 | 0.65 | 0.28 | 8512 |
| 2025-05-13 | CLDX | 19.61 | 0.64 | 999.99 | 8601 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | CLDX | 17.79 | -32.4 | -93.2 | -3.27 |
| 2025-04-15 | CLDX | 18.37 | -32.4 | -74.5 | -3.27 |
| 2025-04-16 | CLDX | 17.81 | -32.4 | -35.3 | -3.27 |
| 2025-04-17 | CLDX | 18.30 | -32.4 | -71.8 | -3.27 |
| 2025-04-18 | CLDX | 18.30 | -32.4 | -53.7 | -3.27 |
| 2025-04-21 | CLDX | 18.97 | -32.4 | -76.2 | -3.27 |
| 2025-04-22 | CLDX | 19.39 | -32.4 | -67.9 | -3.27 |
| 2025-04-23 | CLDX | 19.43 | -32.4 | -55.2 | -3.27 |
| 2025-04-24 | CLDX | 19.57 | -32.4 | -58.0 | -3.27 |
| 2025-04-25 | CLDX | 19.57 | -32.4 | -53.5 | -3.27 |
| 2025-04-28 | CLDX | 21.36 | -32.4 | -105.3 | -3.27 |
| 2025-04-29 | CLDX | 20.93 | -32.4 | -43.5 | -3.27 |
| 2025-04-30 | CLDX | 20.83 | -32.6 | -51.5 | -3.26 |
| 2025-05-01 | CLDX | 20.67 | -32.6 | -50.3 | -3.26 |
| 2025-05-02 | CLDX | 20.66 | -32.6 | -52.5 | -3.26 |
| 2025-05-05 | CLDX | 20.26 | -32.6 | -43.7 | -3.26 |
| 2025-05-06 | CLDX | 18.39 | -32.6 | -3.6 | -3.26 |
| 2025-05-07 | CLDX | 18.91 | -32.6 | -70.8 | -3.26 |
| 2025-05-08 | CLDX | 19.51 | -32.6 | -72.6 | -3.26 |
| 2025-05-09 | CLDX | 18.32 | -32.6 | -19.3 | -3.26 |
| 2025-05-12 | CLDX | 20.18 | -32.6 | -110.4 | -3.26 |
| 2025-05-13 | CLDX | 19.62 | -53.0 | -18.0 | -3.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | CLDX | 0.69 | 3.09 | 12.83 |
| 2025-04-15 | CLDX | 0.69 | 3.09 | 12.83 |
| 2025-04-16 | CLDX | 0.69 | 3.09 | 12.83 |
| 2025-04-17 | CLDX | 0.69 | 3.09 | 12.83 |
| 2025-04-18 | CLDX | 0.69 | 3.09 | 12.83 |
| 2025-04-21 | CLDX | 0.69 | 13.08 | 12.83 |
| 2025-04-22 | CLDX | 0.69 | 13.08 | 12.83 |
| 2025-04-23 | CLDX | 0.69 | 13.08 | 12.83 |
| 2025-04-24 | CLDX | 0.69 | 13.08 | 12.83 |
| 2025-04-25 | CLDX | 0.69 | 13.08 | 12.83 |
| 2025-04-28 | CLDX | 0.69 | 10.42 | 13.57 |
| 2025-04-29 | CLDX | 0.69 | 10.42 | 13.57 |
| 2025-04-30 | CLDX | 0.69 | 10.42 | 13.57 |
| 2025-05-01 | CLDX | 0.69 | 10.42 | 13.57 |
| 2025-05-02 | CLDX | 0.69 | 10.42 | 13.57 |
| 2025-05-05 | CLDX | 0.69 | 10.05 | 13.57 |
| 2025-05-06 | CLDX | 0.69 | 10.05 | 13.57 |
| 2025-05-07 | CLDX | 0.69 | 10.05 | 13.57 |
| 2025-05-08 | CLDX | 0.69 | 10.05 | 13.57 |
| 2025-05-09 | CLDX | 0.69 | 10.05 | 13.57 |
| 2025-05-12 | CLDX | 0.69 | 11.04 | 13.92 |
| 2025-05-13 | CLDX | 0.00 | 11.04 | 13.92 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.81
Avg. EPS Est. Current Quarter
-0.83
Avg. EPS Est. Next Quarter
-0.89
Insider Transactions
Institutional Transactions
11.04
Beta
1.35
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
25
Growth Score
37
Sentiment Score
5
Actual DrawDown %
65.7
Max Drawdown 5-Year %
-73.1
Target Price
57.25
P/E
Forward P/E
PEG
P/S
172.31
P/B
1.85
P/Free Cash Flow
EPS
-2.7
Average EPS Est. Cur. Y
-3.43
EPS Next Y. (Est.)
-4.04
Target Price Estimates Raised
Target Price Estimates Lowered
2
Profit Margin
-2366.07
Relative Volume
0.9
Return on Equity vs Sector %
-49.1
Return on Equity vs Industry %
-32.2
EPS 1 7Days Diff
-0.2
EPS 1 30Days Diff
-0.17
EBIT Estimation
-18
Celldex Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 186
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.
stock quote shares CLDX – Celldex Therapeutics, Inc. Stock Price stock today
news today CLDX – Celldex Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CLDX – Celldex Therapeutics, Inc. yahoo finance google finance
stock history CLDX – Celldex Therapeutics, Inc. invest stock market
stock prices CLDX premarket after hours
ticker CLDX fair value insiders trading